Average Co-Inventor Count = 9.7

ph-index = 7

Forward Citations = 148(Granted Patents)

Location History:

Cambridge, MA (US) (2014)
Stoneham, MA (US) (2006 - 2022)

Company Filing History:

18 out of 2,405

Merck Sharp + Dohme Corp.

Takeda Pharmaceutical Company Limited

Shire Human Genetic Therapies, Inc.

patents

Years Active: 2006-2025

Loading Chart...

33 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12441724 - Inhibitors of plasma kallikrein and uses thereof (2025-10-14),

2. 11352356 - Inhibitors of plasma kallikrein and uses thereof (2022-06-07),

3. 10730874 - Inhibitors of plasma kallikrein and uses thereof (2020-08-04),

4. 9351965 - Indazole derivatives useful as ERK inhibitors (2016-05-31),

5. 9242981 - Fused pyrazole derivatives as novel ERK inhibitors (2016-01-26),

6. 9206142 - Anilinopiperazine derivatives and methods of use thereof (2015-12-08),

7. 9062071 - Substituted piperidines as HDM2 inhibitors (2015-06-23),

8. 8999966 - Compounds that are ERK inhibitors (2015-04-07),

9. 8999957 - Heterocyclic compounds as ERK inhibitors (2015-04-07),

10. 8946216 - Indazole derivatives useful as ERK inhibitors (2015-02-03),

11. 8889683 - Substituted quinoxalines as inhibitors of fatty acid binding protein (2014-11-18),

12. 8859776 - Substituted piperidines that increase p53 activity and the uses thereof (2014-10-14),

13. 8815875 - Inhibitors of fatty acid binding protein (FABP) (2014-08-26),

14. 8759357 - Inhibitors of fatty acid binding protein (FABP) (2014-06-24),

15. 8716483 - Compounds that are ERK inhibitors (2014-05-06),

Title: Inventor Spotlight: Gerald Wayne Shipps, Jr.

Introduction:

Gerald Wayne Shipps, Jr., a prolific inventor hailing from Stoneham, MA, has made significant contributions in the field of pharmaceutical research and development. With an impressive portfolio of 32 patents to his name, Shipps has consistently demonstrated his innovative prowess in the realm of inhibitor compounds.

Latest Patents:

Shipps' recent patents include "Inhibitors of plasma kallikrein and uses thereof," which entail compounds and compositions effective in inhibiting plasma kallikrein with favorable characteristics. The invention showcases Shipps' dedication to advancing pharmaceutical solutions for critical medical needs.

Career Highlights:

Having worked at esteemed companies such as Merck Sharp & Dohme Corporation and Schering Corporation, Shipps has garnered invaluable experience in the pharmaceutical industry. His time at these organizations has undoubtedly shaped his approach to innovation and underscored his commitment to excellence.

Collaborations:

Throughout his career, Shipps has collaborated with notable peers such as Yongqi Deng and Alan B Cooper. These fruitful partnerships have not only enriched Shipps' professional journey but have also led to the development of groundbreaking technologies that have the potential to transform the healthcare landscape.

Conclusion:

In conclusion, Gerald Wayne Shipps, Jr. stands as a visionary inventor whose trailblazing work in pharmaceutical research has left an indelible mark on the industry. His dedication to creating innovative solutions underscores his unwavering passion for driving positive change. As Shipps continues to push the boundaries of scientific exploration, the impact of his inventions is sure to resonate far and wide in the years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.